Back
Relmada Therapeutics Vs. Ensysce Biosciences Industry Stock Comparison
Sell
28
RLMD
Relmada Therapeutics
Last Price:
3.48
Seasonality Move:
-15.59%
Sell
22
ENSC
Ensysce Biosciences
Last Price:
0.64
Seasonality Move:
-26.13%
Sell
28
Relmada Therapeutics (RLMD)
is a Sell
Is Relmada Therapeutics a Buy, Sell or Hold?
- The current Relmada Therapeutics [RLMD] share price is $3.49. The Score for RLMD is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- RLMD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Ensysce Biosciences (ENSC)
is a Sell
Is Ensysce Biosciences a Buy, Sell or Hold?
- The current Ensysce Biosciences [ENSC] share price is $0.63. The Score for ENSC is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- ENSC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RLMD Stock Price Chart
What is Relmada Therapeutics's stock price today?
-
The Relmada Therapeutics share price today is $3.49
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLMD is experiencing slight selling pressure.
ENSC Stock Price Chart
What is Ensysce Biosciences's stock price today?
-
The Ensysce Biosciences share price today is $0.63
The current trend is relatively stagnant and ENSC is experiencing slight buying pressure.
RLMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 35.31 | Sell |
| Chaikin Money Flow: | -14510 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.52 - 4.24) | Sell |
| Bollinger Bands (100): | (3.57 - 5.47) | Sell |
ENSC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 51.72 | Buy |
| Chaikin Money Flow: | 102479 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.54 - 0.64) | Buy |
| Bollinger Bands (100): | (0.63 - 1.21) | Sell |
RLMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.64 | Sell |
| 20-day SMA: | 3.72 | Sell |
| 50-day SMA: | 4.47 | Sell |
| 200-day SMA: | 3.75 | Sell |
| 8-day EMA: | 3.6 | Sell |
| 20-day EMA: | 3.81 | Sell |
| 50-day EMA: | 4.21 | Sell |
| 200-day EMA: | 4.37 | Sell |
ENSC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.57 | Buy |
| 20-day SMA: | 0.57 | Buy |
| 50-day SMA: | 0.69 | Sell |
| 200-day SMA: | 1.15 | Sell |
| 8-day EMA: | 0.59 | Buy |
| 20-day EMA: | 0.6 | Buy |
| 50-day EMA: | 0.7 | Sell |
| 200-day EMA: | 7.9 | Sell |
Relmada Therapeutics Earnings Growth & RLMD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.26 per share.
Ensysce Biosciences Earnings Growth & ENSC Earnings Dates
- Analysts estimate an earnings increase this quarter of $5.03 per share, an increase next quarter of $0.21 per share, an increase this year of $17.95 per share, and an increase next year of $1.37 per share.
Relmada Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ensysce Biosciences Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||